Validation assessment of risk scores to predict postthrombolysis intracerebral haemorrhage

被引:16
作者
Cucchiara, Brett [1 ]
Kasner, Scott [1 ]
Tanne, David [2 ,3 ]
Levine, Steven [4 ]
Demchuk, Andrew [5 ]
Messe, Steve [1 ]
Sansing, Lauren [1 ]
Lees, Kennedy [6 ]
Lyden, Patrick [7 ]
机构
[1] Univ Penn, Med Ctr, Dept Neurol, Philadelphia, PA 19104 USA
[2] Chaim Sheba Med Ctr, Dept Neurol, IL-52621 Tel Hashomer, Israel
[3] Tel Aviv Univ, Tel Hashomer, Israel
[4] Mt Sinai Sch Med, Stroke Ctr, New York, NY USA
[5] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada
[6] Univ Glasgow, Fac Med, Div Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[7] Univ Calif San Diego, Dept Neurol, San Diego, CA 92103 USA
关键词
acute ischaemic stroke; acute stroke thrombolysis; intracerebral haemorrhage; prognosis; thrombolysis; ACUTE ISCHEMIC-STROKE; THROMBOLYTIC THERAPY; NXY-059;
D O I
10.1111/j.1747-4949.2010.00556.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Two clinical risk scores, the Haemorrhage After Thrombolysis and Multicentre Stroke Survey scores, have been proposed to predict the risk of intracerebral haemorrhage following thrombolysis in acute ischaemic stroke. Aims To validate Haemorrhage After Thrombolysis and Multicentre Stroke Survey scores as predictors of post-tissue plasminogen activator symptomatic intracerebral haemorrhage and asymptomatic intracerebral haemorrhage in an independent cohort. Methods Haemorrhage After Thrombolysis and Multicentre Stroke Survey scores were calculated for the cohort of tissue plasminogen activator-treated patients enrolled in the placebo arms of the SAINT-I and SAINT-II trials. The absolute risk of symptomatic intracerebral haemorrhage and asymptomatic intracerebral haemorrhage associated with each scoring system was determined. The overall predictive value was assessed using c-statistics. Results Symptomatic intracerebral haemorrhage occurred in 5 center dot 6% of 965 patients treated with tissue plasminogen activator in the SAINT cohorts. The risk of symptomatic intracerebral haemorrhage was modestly greater, with higher Haemorrhage After Thrombolysis scores (0: 4 center dot 1%, 1: 4 center dot 1%, 2: 8 center dot 8%, 3: 12 center dot 5%, 4: 0%, 5: no subjects). Similar results were seen with the Multicentre Stroke Survey score (0: 0%, 1: 4 center dot 8%, 2: 2 center dot 3%, 3: 7 center dot 3%, 4: 6 center dot 3%). In logistic regression, the Haemorrhage After Thrombolysis score was associated with the risk of symptomatic intracerebral haemorrhage (odds ratio=1 center dot 41 per point, 95% confidence interval: 1 center dot 05-1 center dot 89, P=0 center dot 021) and asymptomatic intracerebral haemorrhage (odds ratio=1 center dot 59 per point, 95% confidence interval: 1 center dot 33-1 center dot 92, P < 0 center dot 001). The Multicentre Stroke Survey score was modestly associated with the risk of symptomatic intracerebral haemorrhage (odds ratio=1 center dot 43 per point, 95% confidence interval: 0 center dot 95-2 center dot 15, P=0 center dot 084) and asymptomatic intracerebral haemorrhage (odds ratio=1 center dot 63 per point, 95% confidence interval: 1 center dot 27-2 center dot 08, P < 0 center dot 001). The c-statistic was 0 center dot 59 for predicting symptomatic intracerebral haemorrhage and 0 center dot 61 for asymptomatic intracerebral haemorrhage for both the Haemorrhage After Thrombolysis and the Multicentre Stroke Survey scores. Conclusions While both the Haemorrhage After Thrombolysis and Multicentre Stroke Survey scores were associated with a risk of symptomatic intracerebral haemorrhage, discriminatory ability was limited.
引用
收藏
页码:109 / 111
页数:3
相关论文
共 8 条
  • [1] Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy
    Barber, PA
    Demchuk, AM
    Zhang, JJ
    Buchan, AM
    [J]. LANCET, 2000, 355 (9216) : 1670 - 1674
  • [2] Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke -: A multicenter confirmatory study
    Castellanos, Mar
    Sobrino, Tomas
    Millan, Monica
    Garcia, Maria
    Arenillas, Juan
    Nombela, Florentino
    Brea, David
    de la Ossa, Natalia Perez
    Serena, Joaquin
    Vivancos, Jose
    Castillo, Jose
    Davalos, Antoni
    [J]. STROKE, 2007, 38 (06) : 1855 - 1859
  • [3] Cucchiara Brett, 2008, J Stroke Cerebrovasc Dis, V17, P331, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.012
  • [4] Extent of early ischemic changes on computed tomography (CT) before thrombolysis - Prognostic value of the Alberta Stroke Program Early CT Score in ECASS II
    Dzialowski, I
    Hill, MD
    Coutts, SB
    Demchuk, AM
    Kent, DM
    Wunderlich, O
    von Kummer, R
    [J]. STROKE, 2006, 37 (04) : 973 - 978
  • [5] NXY-059 for acute ischemic stroke
    Lees, KR
    Zivin, JA
    Ashwood, T
    Davalos, A
    Davis, SM
    Diener, H
    Grotta, J
    Lyden, P
    Shuaib, A
    Hårdemark, H
    Wasiewski, WW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) : 588 - 600
  • [6] The HAT Score A simple grading scale for predicting hemorrhage after thrombolysis
    Lou, M.
    Safdar, A.
    Mehdiratta, M.
    Kumar, S.
    Schlaug, G.
    Caplan, L.
    Searls, D.
    Selim, M.
    [J]. NEUROLOGY, 2008, 71 (18) : 1417 - 1423
  • [7] NXY-059 for the treatment of acute ischemic stroke
    Shuaib, Ashfaq
    Lees, Kennedy R.
    Lyden, Patrick
    Grotta, James
    Davalos, Antonio
    Davis, Stephen M.
    Diener, Hans-Christoph
    Ashwood, Tim
    Wasiewski, Warren W.
    Emeribe, Ugochi
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (06) : 562 - 571
  • [8] Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption
    Warach, S
    Latour, LL
    [J]. STROKE, 2004, 35 (11) : 2659 - 2661